MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

06 Feb 2025 Evaluate
The sales moved down -70.73% to Rs. 0.96 millions for the December 2024 quarter as compared to Rs. 3.28 millions during the corresponding quarter last year.A big loss of -86.05% reported for the quarter ended December 2024 to Rs. 0.18  millions from Rs. 1.29 millions.Operating profit for the quarter ended December 2024 decreased to 1.55 millions as compared to 3.19 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 0.96 3.28 -70.73 5.15 4.80 7.29 5.55 10.19 -45.53
Other Income 4.34 5.25 -17.33 14.01 15.09 -7.16 19.92 17.51 13.76
PBIDT 1.55 3.19 -51.41 7.68 8.14 -5.65 9.10 10.60 -14.15
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 1.55 3.19 -51.41 7.68 8.14 -5.65 9.10 10.60 -14.15
Depreciation 0.24 0.24 0.00 0.72 0.72 0.00 0.98 0.94 4.26
PBT 1.31 2.95 -55.59 6.96 7.42 -6.20 8.12 9.66 -15.94
TAX 1.13 1.66 -31.93 3.10 3.62 -14.36 0.62 4.63 -86.61
Deferred Tax 1.42 0.76 86.84 2.09 1.46 43.15 0.19 2.12 -91.04
PAT 0.18 1.29 -86.05 3.86 3.80 1.58 7.50 5.03 49.11
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 161.46 97.26 66.01 149.13 169.58 -12.06 163.96 104.02 57.62
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..